Detalhe da pesquisa
1.
Long-Term Opioid Therapy Among Patients With Systemic Lupus Erythematosus in the Community: A Lupus Midwest Network (LUMEN) Study.
J Rheumatol
; 50(4): 504-511, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36379579
2.
Health Care Utilization in Systemic Lupus Erythematosus in the Community: The Lupus Midwest Network.
J Clin Rheumatol
; 29(1): 29-35, 2023 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251449
3.
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance.
Ann Rheum Dis
; 81(7): 970-978, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172961
4.
Epidemiology of Antiphospholipid Syndrome in the General Population.
Curr Rheumatol Rep
; 23(12): 85, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34985614
5.
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.
Ann Rheum Dis
; 80(9): 1137-1146, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049860
6.
Incidence, Prevalence, and Mortality of Lupus Nephritis: A Population-Based Study Over Four Decades Using the Lupus Midwest Network.
Arthritis Rheumatol
; 75(4): 567-573, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36227575
7.
Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology Alliance.
Arthritis Care Res (Hoboken)
; 75(1): 53-60, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239292
8.
Epidemiology of Cutaneous Lupus Erythematosus Among Adults Over Four Decades (1976-2018): A Lupus Midwest Network (LUMEN) Study.
Mayo Clin Proc
; 97(12): 2282-2290, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36347648
9.
Epidemiology of Childhood-Onset Systemic Lupus Erythematosus: A Population-Based Study.
Arthritis Care Res (Hoboken)
; 74(5): 728-732, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34825516
10.
Industry involvement in rheumatology consensus-based recommendations: a systematic review.
Lancet Rheumatol
; 4(2): e145-e152, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38288738
11.
Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study.
Lancet Rheumatol
; 4(11): e765-e774, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36118532
12.
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry.
ACR Open Rheumatol
; 4(10): 872-882, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869686
13.
COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance.
J Rheumatol
; 49(1): 110-114, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34470798
14.
Environmental and societal factors associated with COVID-19-related death in people with rheumatic disease: an observational study.
Lancet Rheumatol
; 4(9): e603-e613, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35909441
15.
The protective effect of rheumatic disease agents in COVID-19.
Best Pract Res Clin Rheumatol
; 35(1): 101659, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33526326
16.
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
JAMA Netw Open
; 4(10): e2129639, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34661663